The deal provides a clear premium to HOWL's current $20M market cap, but the massive dilution (HOWL holders get ~6.8% of the combined entity) and execution risk around the PIPE and stockholder approvals create a binary event. Monitor the Form S-4 filing and stockholder vote timelines for deal progression signals.
Price Chart
Executive Summary
Werewolf Therapeutics (HOWL) filed a Form 8-K (filed as a 425 communication) confirming the definitive merger agreement to be acquired by Ambros Therapeutics in a reverse-merger transaction. The combined company will be valued at an implied $500M for Ambros' equity, with Werewolf shareholders receiving a fixed equity value of $47.5M (subject to a $5.5M floor) plus contingent value rights (CVRs) tied to legacy pipeline assets WTX-124 and WTX-330. A concurrent $150M PIPE financing is committed, and the deal requires stockholder approvals from both companies with an expected close by January 29, 2027. For HOWL shareholders, this represents a significant premium to the current $20M market cap but introduces substantial dilution and execution risk tied to the merger and PIPE closing conditions.
Key Financial Metrics
Key Facts
- Werewolf entered into a definitive merger agreement to be acquired by Ambros Therapeutics in a reverse merger.
- Werewolf shareholders receive a fixed equity value of $47.5M (subject to a $5.5M floor) plus CVRs tied to legacy pipeline assets.
- A concurrent $150M PIPE financing is committed to fund the combined entity.
- Pre-merger Werewolf equityholders (non-PIPE) expected to own ~6.8% of the combined company; pre-merger Ambros stockholders ~71.7%; PIPE investors ~21.5%.
- The deal is expected to close by January 29, 2027, subject to stockholder approvals and other conditions.
- Ambros termination fee is $20M; Werewolf termination fee is $1.9M.
Financial Impact
Werewolf shareholders receive $47.5M in fixed equity value (subject to net cash adjustments with a $5.5M floor) plus CVRs for legacy assets. A $150M PIPE is committed. The implied valuation for Ambros is $500M.
Risk Factors
- Risk of deal failure if stockholder approvals are not obtained or PIPE conditions are not met.
- Massive dilution for existing HOWL shareholders, who will own only ~6.8% of the combined company.
- Execution risk in the reverse merger and integration of Ambros' business.
- CVR payments for legacy assets are contingent and may result in no payout.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (HOWL) — Batch item 1 | 0001193125-26-360063 |
| Document: 0001193125-26-360063-index-headers.html | 0001193125-26-360063 |
| Document: 0001193125-26-360063-index.html | 0001193125-26-360063 |
| Document: 0001193125-26-360063.txt | 0001193125-26-360063 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-4/A | $0.9806 | awaiting T+5 | — | $0.9810 (−0.04%) |
Sep 22, 2026 4w ago | S-4 | $0.9894 $0.9223 | ▲ +6.78% | ▲ +6.11% | $0.9810 (+0.85%) |
Sep 21, 2026 5w ago | SC 13G | $0.9800 $0.9300 | ▼ −5.10% | ▼ −4.08% | $0.9810 (+0.10%) |
Aug 21, 2026 9w ago | 425 | $0.8740 $0.9433 | ▲ +7.93% | ▲ +7.46% | $0.9810 (+12.24%) |
Aug 21, 2026 9w ago | 8-K | $0.8740 $0.9433 | ▲ +7.93% | ▲ +7.46% | $0.9810 (+12.24%) |
Aug 21, 2026 9w ago | Press Release | $0.8740 $0.9433 | ▼ −7.93% | ▼ −7.46% | $0.9810 (−12.24%) |
Jul 31, 2026 12w ago | 8-K | $0.3531 $0.3971 | ▲ +12.46% | ▲ +8.95% | $0.9810 (+177.82%) |
Jul 31, 2026 12w ago | Press Release | $0.3531 $0.3971 | ▲ +12.46% | ▲ +8.95% | $0.9810 (+177.82%) |
Jun 29, 2026 17w ago | 144 | $0.3599 $0.3200 | ▲ +11.09% | ▲ +11.69% | $0.9810 (−172.58%) |
Jun 29, 2026 17w ago | 144 | $0.3599 $0.3200 | ▲ +11.09% | ▲ +11.69% | $0.9810 (−172.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers